• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Replies
20
Views
3K
Replies
19
Views
2K
Replies
5
Views
854
Replies
18
Views
2K
Replies
9
Views
212
Replies
25
Views
2K
Replies
4
Views
568